Comera Life Sciences Holdings, Inc.CMRA
| Dec 31, 2022 |
---|
Cash and cash equivalents | 446,607 |
---|
Restricted Cash, Current | 2 |
---|
Accounts receivable | 34,320 |
---|
Deferred issuance costs | 0 |
---|
Prepaid expenses and other current assets | 986,499 |
---|
Total current assets | 3 |
---|
Restricted Cash, Noncurrent | 50,000 |
---|
Property and equipment, net | 257,186 |
---|
Right of use asset | 313,629 |
---|
Security deposit | 43,200 |
---|
Total assets | 4 |
---|
Accounts payable | 1 |
---|
Accrued Liabilities, Current | 1 |
---|
Insurance premium financing | 455,562 |
---|
Deposit liability | 2 |
---|
Deferred revenue | 144,280 |
---|
Lease liability - current | 199,184 |
---|
Total current liabilities | 5 |
---|
Derivative warrant liabilities | 277,507 |
---|
Lease liability - noncurrent | 120,302 |
---|
Total liabilities | 5 |
---|
Convertible preferred stock | 5 |
---|
Common Stock, Value, Issued | 1,671 |
---|
Additional paid-in capital | 29 |
---|
Accumulated deficit | -35 |
---|
Total stockholders' deficit | -6,247,088 |
---|
Total liabilities, convertible preferred stock and stockholders' deficit | 4 |
---|